AP2004003145A0 - Azithromycin dosage forms with reducted side effects - Google Patents

Azithromycin dosage forms with reducted side effects

Info

Publication number: AP2004003145A0
Authority: AP; ARIPO
Prior art keywords: reducted; dosage forms; side effects; azithromycin dosage; azithromycin
Prior art date: 2003-12-04

Application number

AP2004003145A

Other versions

AP2218A (en

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-04

Filing date

2004-05-14

Publication date

2004-09-30

2004-05-14 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-05-14 Priority claimed from PCT/IB2004/001654 external-priority patent/WO2005053650A1/en

2004-09-30 Publication of AP2004003145A0 publication Critical patent/AP2004003145A0/en

2011-04-20 Application granted granted Critical

2011-04-20 Publication of AP2218A publication Critical patent/AP2218A/en

Links

APAP/P/2004/003145A 2003-12-04 2004-05-14 Azithromycin dosage forms with reduced side effects AP2218A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US52708403P	2003-12-04	2003-12-04
PCT/IB2004/001654 WO2005053650A1 (en)	2003-12-04	2004-05-14	Azithromycin dosage forms with reduced side effects

Publications (2)

Publication Number	Publication Date
AP2004003145A0 true AP2004003145A0 (en)	2004-09-30
AP2218A AP2218A (en)	2011-04-20

Family

ID=34699855

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
APAP/P/2004/003145A AP2218A (en)	2003-12-04	2004-05-14	Azithromycin dosage forms with reduced side effects

Country Status (8)

Country	Link
CN (1)	CN1697648B (en)
AP (1)	AP2218A (en)
AU (1)	AU2004216676B2 (en)
EC (1)	ECSP045351A (en)
GT (1)	GT200400183A (en)
TN (1)	TNSN05319A1 (en)
UA (1)	UA78793C2 (en)
ZA (1)	ZA200408075B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA200805793B (en) *	2005-12-22	2009-11-25	Otsuka Pharma Co Ltd	Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol
CN103054813A (en) *	2012-12-31	2013-04-24	广东先强药业有限公司	Azithromycin oral sustained-release dry suspension and preparation method thereof
CN104177457A (en) *	2013-05-23	2014-12-03	长春海悦药业有限公司	Azithromycin drug raw material, and preparation and application thereof
CA2978322A1 (en) *	2015-03-10	2016-09-15	Lumos Pharma, Inc.	Cyclocreatine microsuspension
CN110381960A (en) *	2017-02-02	2019-10-25	麦克马斯特大学	The bicarbonate of reinforcing agent as antimicrobial
CN114213484A (en) *	2021-12-21	2022-03-22	河北远征药业有限公司	Tildipirosin 1, 2-propylene glycol solvent compound and preparation method thereof
CN115212173B (en) *	2022-07-11	2024-10-15	上海现代药物制剂工程研究中心有限公司	Ambroxol hydrochloride spherical slow-release particles, preparation method and application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW271400B (en) *	1992-07-30	1996-03-01	Pfizer
US5605889A (en) *	1994-04-29	1997-02-25	Pfizer Inc.	Method of administering azithromycin
CN1123279A (en) *	1995-06-15	1996-05-29	沈家祥	Azithmycin water-soluble salt, injection thereof and their usage
PL372394A1 (en) *	2002-02-01	2005-07-25	Pfizer Products Inc.	Dry granulated formulations of azithromycin

2004
- 2004-05-14 UA UA20041210181A patent/UA78793C2/en unknown
- 2004-05-14 CN CN200480000209.2A patent/CN1697648B/en not_active Expired - Lifetime
- 2004-05-14 AU AU2004216676A patent/AU2004216676B2/en not_active Expired
- 2004-05-14 AP APAP/P/2004/003145A patent/AP2218A/en active
- 2004-09-16 GT GT200400183A patent/GT200400183A/en unknown
- 2004-10-06 ZA ZA200408075A patent/ZA200408075B/en unknown
- 2004-10-08 EC ECSP045351 patent/ECSP045351A/en unknown
2005
- 2005-12-14 TN TNP2005000319A patent/TNSN05319A1/en unknown

Also Published As

Publication number	Publication date
AU2004216676A1 (en)	2005-06-23
UA78793C2 (en)	2007-04-25
AU2004216676B2 (en)	2011-06-16
ECSP045351A (en)	2005-01-28
TNSN05319A1 (en)	2007-07-10
AP2218A (en)	2011-04-20
CN1697648A (en)	2005-11-16
ZA200408075B (en)	2007-01-31
GT200400183A (en)	2005-10-24
CN1697648B (en)	2010-06-23

Similar Documents

Publication	Publication Date	Title
IL164165A0 (en)	2005-12-18	Azithromycin dosage forms with reduced side effects
GB2409786B (en)	2006-12-13	Content distribution
HU0302451D0 (en)	2003-10-28	New compounds with therapeutic effect
ZA200705108B (en)	2009-01-28	Macrolides
GB0411850D0 (en)	2004-06-30	Spacing arrangement
GB0704141D0 (en)	2007-04-11	Topical medicament
EP1670408A4 (en)	2009-07-15	Improved obturators
EP1607316A4 (en)	2006-05-17	Combine
PL377236A1 (en)	2006-01-23	Indazolamides with analgesic activity
AP2004003145A0 (en)	2004-09-30	Azithromycin dosage forms with reducted side effects
GB0512453D0 (en)	2005-07-27	Dosage unit
GB0319607D0 (en)	2003-09-24	Retaining arrangement
IL180487A0 (en)	2007-06-03	Medicament
GB0315019D0 (en)	2003-07-30	Dosage form
GB0426942D0 (en)	2005-01-12	Medicament
GB0409098D0 (en)	2004-05-26	Medicament
GB0515452D0 (en)	2005-08-31	Bulking system
GB0315220D0 (en)	2003-08-06	Subverts
IL156581A0 (en)	2004-01-04	Straight corticotomo-osteotome
GB2408292B (en)	2006-10-11	The decelerator
GB0327913D0 (en)	2004-01-07	Medicament
GB0301842D0 (en)	2003-02-26	Medicament
GB0327912D0 (en)	2004-01-07	Medicament
GB0329657D0 (en)	2004-01-28	Macrolides
GB0301602D0 (en)	2003-02-26	Multi-plug